Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation

This publication has 55 references indexed in Scilit:

• Molecular biology of PCSK9: its role in LDL metabolism
  Trends in Biochemical Sciences, 2007
• Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
  Journal of Clinical Investigation, 2006
• Molecular Characterization of Loss-of-Function Mutations in PCSK9 and Identification of a Compound Heterozygote
  American Journal of Human Genetics, 2006
• Reading protein modifications with interaction domains
  Nature Reviews Molecular Cell Biology, 2006
• Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9
  Proceedings of the National Academy of Sciences, 2005
• Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
  Proceedings of the National Academy of Sciences, 2004
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
  Proceedings of the National Academy of Sciences, 2003
• NMR structure and backbone dynamics of a concatemer of epidermal growth factor homology modules of the human low-density lipoprotein receptor
  Journal of Molecular Biology, 2001
• The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
  Cell, 1984